Plus   Neg

Alexion Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

Alexion Pharmaceuticals Inc. (ALXN) announced earnings for its first quarter that climbed from last year.

The company's bottom line totaled $587.9 million, or $2.61 per share. This compares with $249.1 million, or $1.11 per share, in last year's first quarter.

Excluding items, Alexion Pharmaceuticals Inc. reported adjusted earnings of $545.5 million or $2.39 per share for the period.

Analysts had expected the company to earn $2.19 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 22.6% to $1.14 billion from $0.93 billion last year.

Alexion Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q1): $545.5 Mln. vs. $380.6 Mln. last year.
-EPS (Q1): $2.39 vs. $1.68 last year.
-Analysts Estimate: $2.19
-Revenue (Q1): $1.14 Bln vs. $0.93 Bln last year.

Full year EPS guidance: $9.25 to $9.45
Full year revenue guidance: $4,675 to $4,750 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT